Pay in 4 interest-free payments of $7.23 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Other Heart Tests An EKG is a first-line tool, but its often part of a broader cardiac evaluation
FDA approval is expected in 2026
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
May decrease pain in damaged areas of the body
We produce unique acetylated and amidated peptide structures that reflect structural features studied in naturally occurring peptides and are not standard across all peptide production processes
US$ 29.40
US$ 23.93
US$ 22.48
US$ 21.00
